NAVINFLUORNSEFinancial Year 2025-26July 30, 2025

Navin Fluorine International Limited

3,381words
5turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
July 30, 2025 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai 400001 Scrip Code: 532504 Dear Sir / Madam, National Stock Exchange
Rs. 725.4
tements and projections. 2 Q1FY26 Financial Performance Q1FY26 - Performance at a glance Sales Rs. 725.4 Crs + 39% Y-o-Y Operating EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935
39%
ctions. 2 Q1FY26 Financial Performance Q1FY26 - Performance at a glance Sales Rs. 725.4 Crs + 39% Y-o-Y Operating EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y
Rs. 206.8
Performance Q1FY26 - Performance at a glance Sales Rs. 725.4 Crs + 39% Y-o-Y Operating EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 14
106%
Y26 - Performance at a glance Sales Rs. 725.4 Crs + 39% Y-o-Y Operating EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y +
28.5%
s Rs. 725.4 Crs + 39% Y-o-Y Operating EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-
935 bps
.4 Crs + 39% Y-o-Y Operating EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-o-Q + 23%
Rs. 141.2
g EBITDA Rs. 206.8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-o-Q + 23% Q-o-Q 6 2 Y F 1 Q Revenue Gr
143%
8 Crs + 106% Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-o-Q + 23% Q-o-Q 6 2 Y F 1 Q Revenue Growth (Y-o-Y
3%
Y-o-Y Operating EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-o-Q + 23% Q-o-Q 6 2 Y F 1 Q Revenue Growth (Y-o-Y) HPP 45%
16%
ting EBITDA Margin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-o-Q + 23% Q-o-Q 6 2 Y F 1 Q Revenue Growth (Y-o-Y) HPP 45% Consolidated
301 bps
rgin 28.5% + 935 bps Y-o-Y Operating PBT Rs. 141.2 Crs + 143% Y-o-Y + 3% Q-o-Q + 16% Q-o-Q + 301 bps Q-o-Q + 23% Q-o-Q 6 2 Y F 1 Q Revenue Growth (Y-o-Y) HPP 45% Consolidated Financials Speci
Guidance — 3 items
Strategy -in-action
opening
• EU Major – Material order received for supply in Q2FY26 • Another EU Major – Scale up order expected in Q2FY26 • US Major – Commercial order expected for delivery in FY26 ( Scale-up order delivered) ✓ cGMP4 capex for Rs.
Strategy -in-action
opening
160 crore on track to commission by end of Q3FY26 7 Consolidated Profitability Statement Particulars (Rs.
Resilient business model
opening
22 Investing in community well-being Total CSR expenditure for FY25 Rs.
Advertisement
Speaking time
European CDMO MSA
1
Strategy -in-action
1
Resilient business model
1
CSR contribution made to
1
Investor Relations Advisors
1
Opening remarks
Strategy -in-action
• EU Major – Material order received for supply in Q2FY26 • Another EU Major – Scale up order expected in Q2FY26 • US Major – Commercial order expected for delivery in FY26 ( Scale-up order delivered) ✓ cGMP4 capex for Rs. 288 crore – Phase 1 capex of Rs. 160 crore on track to commission by end of Q3FY26 7 Consolidated Profitability Statement Particulars (Rs. Crs.) Net Revenue From Operations Raw Material Employee Expenses Other Expenses Operating EBITDA Operating EBITDA Margin Interest Expenses Depreciation Operating PBT Operating PBT Margin Other Income Exceptional Items* Profit Before Tax Tax Profit After Tax (Loss) From Associates And Joint Venture (Net) Other Comprehensive Income Items That Will Not Be Reclassified To Profit & Loss (Net Of Tax) Items That May Be Reclassified To Profit And Loss Total Comprehensive Income For The Period Q1 FY26 Q1 FY25 725.40 307.71 77.57 133.33 206.79 28.51% 30.35 35.24 141.20 19.47% 13.91 0.00 155.11 37.94 117.17 -0.01 -1.27 1.71 117.60 523.68 230
Resilient business model
diversified divisions, products, plants & end markets 3 Geographies 4 Countries 3 Business Verticals 4 Factories 3 R&D Centres 5 Sales Offices 900+ Total Customers 1,498 Total Employees Preferred source and a partner of choice for diverse fluorochemical solutions globally Leveraging our fluorochemicals expertise, world-class manufacturing facilities, dynamic in-house R&D, advanced technologies and competent workforce, we have developed a comprehensive and diversified portfolio, encompassing: Specialty Chemicals Contract Research and Development Services High Performance Products 11 3P approach to building capacities, building scalable platforms and nurturing long- term partnerships Diverse portfolio including fluorine- based intermediates, specialty chemicals and inorganic chemicals Product 3P FOCUS Partnerships Platform Forging multiyear partnerships to integrate within the global supply chain positioning alongside industry majors Harnessing their expertise and resources to expand our
CSR contribution made to
SHRI SADGURU SEVA SANGH TRUST ACT-EVE FOUNDATION CHARUTAR AROGYA MANDAL SHALA PRAVESHOTSAV BLIND PEOPLE’S ASSOCIATION CANCER PATIENT AID ASSOCIATION FOUNDATION FOR PROMOTION OF SPORTS KC MAHINDRA EDUCATION TRUST SIR J.J. HOSPITAL SHAKTI FOUNDATION CONSUMER EDUCATION AND RESEARCH CENTRE MOBILE HEALTH VANS 23 Track record of progressive dividends Dividend as % of Face Value Special Final Interim Payout %* 750% 600% 65% 85% FY12 140% 75% 65% FY10 150% 85% 65% FY11 750% 150% 550% 550% 550% 600% 600% 500% 150% 180% 390 200% 150% 400% 315% 75% 130% 210% 110% 100% 110% 170% 190% 300% 300% 350% 350% 350% 250% 250% 250% 250% 250% FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 150% 75% 75% FY13 160% 160% 85% 75% FY14 85% 75% FY15 22% 24% 37% 40% 36% 38% 29% 28% 33% 31% 30% 23% 20% 19% 32% 25% * On standalone basis 24 For further information, please contact: Navin Fluorine International Ltd. CIN : L24110MH1998PLC115499 anish.ganatra@nfil.in Mr. Anish Ganatra Chief Financial Officer anish.ganat
Investor Relations Advisors
MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Ms. Payal Dave payal.dave@in.mpms.mufg.com payal.dave@in.mpms.mufg.com Ms. Pooja Swami pooja.swami@in.mpms.mufg.com pooja.swami@in.mpms.mufg.com Meeting Request Link LinkLink
Advertisement
← All transcriptsNAVINFLUOR stock page →